Summary
Eicosanoids (prostaglandins, leukotrienes, thromboxane A2 and other metabolites of C-20 polyunsaturated fatty acids) have numerous effects in the cardiovascular system. Direct inotropic actions have been repeatedly described, but appear in only very few cases to be due to direct modification of the inotropic state of the heart. Specific eicosanoid receptors have been identified on the surface of the sarcolemmal membrane. Signal transduction pathways in the cardiac myocyte involve the adenylate cyclase/cAMP system or stimulation of the phospholipase C/IP3 pathway. In general, concentrations of eicosanoids which affect myocardial contractility are higher as the response is less predictable than the effects on platelet function or vessel tone. Therefore, eicosanoid-induced extracardiac effects may be superimposed to more direct changes in the contractile state of the intact heart in vitro or in vivo. In contrast to non-failing hearts, there is a significant improvement of the contractile function in contractile failure (“stunning”, ischemia, congestive heart failure) by vasodilating prostaglandins (e.g., PGI2). The mechanism of this action is still unknown.
References
Allan G, Levi R (1980) The cardiac effects of prostaglandins and their modification by the prostaglandin antagonist N-0164. J Pharm Exp Ther 214:45–49
Alloatti G, Serazzi L, Levi RC (1991) Prostaglandin I2 (PGI2) enhances calcium current in guinea-pig ventricular heart cells. J Mol Cell Cardiol 23:851–860
Auclair MC, Vernimmen C, Lechat P (1988) Influence of prostacyclin and two metabolites om the contractility of cultured rat heart cells. Prostaglandins Leukotr Essent Fatty Acids 32:33–38
Auinger C, Weissel M, Bergmann H, Sinzinger H (1988) Einfluß von PGE1 auf die linksventrikuläre Auswurffraktion. Wien Klin Wochenschr 100:706–709
Awan NA, Evenson MK, Needham KE, Beattie JM, Amsterdam ED, Mason DT (1981) Cardiocirculatory and myocardial energetic effects of prostaglandin E1 in severe left ventricular failure due to chronic coronary heart disease. Am Heart J 102:703–709
Bjoernsson OG, Kobayashi K, Williamson JR (1987) Interaction between leukotriene D4 and adenosine or iloprost in the isolated working guinea-pig heart: prevention of the leukotriene D4 effect. Eur J Clin Invest 17:146–155
Borda LS, Cangas L, Gimeno MF, Gimeno AL (1979) An adrenergic participation subserving a positive inotropism and chronotropism of prostacyclin on isolated rat atria. Experientia 35:529–530
Burke JA, Levi R, Guo ZG, Corey EJ (1982) Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro. J Pharmacol Exp Ther 221:235–241
Cannon PJ (1986) Prostaglandins in congestive heart failure and the effects of nonsteroidal antiinflammatory drugs. Am J Med 81:123–132
Couttenye MM, De Clerck NM, Herman AG, Brutsaert DL (1985) Effects of prostacyclin on contractile properties of isolated mammalian cardiac muscle. J Cardiovasc Pharmacol 7:971–976
Das UN, Lee AM, Barritt GJ (1983) Prostanoids can modify response to electrical stimulus and45Ca2+ exchange in isolated myocardial muscle cells. Prostaglandins Leukotr Med 12:305–314
Dzau VJ, Packer M, Lilly LS, Swartz SL, Hollenberg NK, Williams GH (1984) Prostaglandins in severe congestive heart failure. Relation to activation of the renin-angiotensin system and hyponatremia. New Engl J Med 310:347–352
Falcone RC, Aharony D, Orzechowski F (1991) Evidence for leukotriene D4 receptors in guinea pig left atria. J Pharmacol Exp Ther 258:199–206
Farber NE, Gross GJ (1989) Prostaglandin E1 attenuates postischemic contractile dysfunction after brief coronary occlusion and reperfusion. Am Heart J 118:17–24
Farber NE, Gross GJ (1990) Prostaglandin redirection by thromboxane synthetase inhibition. Circulation 81:369–380
Farber NE, Pieper GM, Thomas JP, Gross GJ (1988) Beneficial effects of iloprost in the stunned canine myocardium. Circ Res 62:204–215
Fassina G, Tessari F, Dorigo P (1983) Positive inotropic effect of a stable analogue of PGI2 and of isolated guinea pig atria. Mechanism of action. Pharmacol Res Commun 15:735–749
Garlick PB, Mashiter GD, Di Marzo V, Tippins JR, Morris HR, Maisey MN (1989) The synthesis, release and action of leukotrienes in the isolated, unstimulated, buffer-perfused rat heart. J Mol Cell Cardiol 21:1101–1110
Hattori Y, Levi R (1984) Negative inotropic effect of leukotrienes: leukotrienes C4 and D4 inhibit calcium-dependent contractile responses in potassium-depolarized guinea-pig myocardium. J Pharmacol Exp Ther 230:646–651
Hattori Y, Levi R (1986) Effect of PGD2 on cardiac contractility: a negative inotropism secondary to coronary vasoconstriction conceals a primary positive inotropic action. J Pharm Exp Ther 237:719–724
Hayes JB, Bowling N, King KL, Boder GB (1982) Evidence for selective regulation of the phosphorylation of myocyte proteins by isoproterenol and prostaglandin E1. Biochim Biophys Acta 714:136–142
Härtel B, Morwinski R, Heydeck D, Papies B (1991) Arachidonic acid metabolism in cultured adult myocardial cells under short-time hypoxic conditions. Mol Cell Biochem 106:67–74
Hedqvist P, Wennmalm A (1971) Comparison of the effects of prostaglandins E1, E2 and F2α on the sympathetically stimulated rabbit heart. Acta Physiol Scand 83:156–162
Herman RP, Heller RS, Canavan CM, Herman CA (1988) Leukotriene C4 action and metabolism in the isolated perfused bullfrog heart. Can J Physiol Pharmacol 66:980–984
Hogaboom GK, Mong S, Stadel JM, Crooke ST (1985) Characterization of guinea pig myocardial leukotriene C4 binding sites. Regulation by cations and sulfhydryl-directed agents. Mol Pharmacol 27:236–245
Hohl CM, Rösen P (1987) The role of arachidonic acid in rat heart cell metabolism. Biochim Biophys Acta 921:356–360
Hohlfeld Th, Strobach H, Schrör K (1991) Stimulation of prostacyclin synthesis by defibrotide: improved contractile recovery from myocardial ‘stunning’. J Cardiovasc Pharmacol 17:108–115
Holzgrefe HH, Buchanan LV, Bunting S (1987) In vivo characterization of synthetic thromboxane A2 in canine myocardium. Circ Res. 60:290–966
Huang JM, Xian Hu, Bacaner M (1991) Leukotrienes and prostaglandins signal biologic actions by modulating calcium current in guinea pig myocytes. Circulation 84: (Suppl II) II-209
Huang JM, Xian Hu, Bacaner M (1990) Arachidonic acid and metabolites modulate calcium currents in single ventricular myocytes. Circulation 83: (Suppl III) III-525
Kangasaho M, Metsae-Ketelae T, Vapaatalo H (1978) Effects of prostaglandins on rat cardiac adenylate cyclase. Eur J Pharmacol 52:93–98
Karmazyn M, Dhalla NS (1979) Thromboxane B2: a cardiodepressant of isolated rat hearts and inhibitor of sarcolemma Na+ and K+ stimulated ATPase activity. Prostaglandins Med 3:81–93
Karmazyn M, Moffat MP (1990) Positive inotropic effects of low concentrations of leukotrienes C4 and D4 in rat heart. Am J Physiol 259:H1239-H1246
Kaumann AJ, Birnbaumer L (1974) Prostaglandin E1 action on sinus pacemaker and adenylyl cyclase in kitten myocardium. Nature 251:515–517
Keely SL (1979) Prostaglandin E1 activation of heart cAMP-dependent protein kinase: apparent dissociation of protein kinase activation from increases in phosphorylase activity and contractile force. Mol Pharmacol 15:235–245
Krebs R, Schrör K (1975) Actions of prostaglandin E2 on myocardial mechanisms, coronary vascular resistance and oxygen consumption in the guinea-pig isolated heart preparation. Br J Pharmacol 55:403–408
Krzeminski T, Kurcok A, Juraszczyk Z, Kozik W, Kapustecki J, Kryj M, Brus R (1987) Influence of verapamil on central and peripheral effects of prostacyclin on circulatory system in rats. Med Biol 65:249–253
Letts LG, Piper PJ (1982) The actions of leukotrienes C4 and D4 on guinea-pig isolated hearts. Br J Pharmacol 76:169–176
Lopaschuk GD, Michalak M, Wandler EL, Lerner RW, Piscione TD, Coceani F, Olley PM (1989) Prostaglandin E receptors in cardiac sarcolemma. Circ Res 65:538–545
Metsae-Ketelae T (1981) Cyclic AMP dependent and -independent effects of prostaglandins on the contraction-relaxation cycle of spontaneously beating rat atria. Acta Physiol Scand 112:481–485
Mironeau J, Grosset A (1976) Ionic mechanism of inotropic effect of prostaglandin E1 on frog atrial muscle. Pflüger's Arch 366:79–81
Morgan JP (1991) Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. New Engl J Med 325:625–632
Mullane KM, Fornabaio D (1988) Thromboxane synthetase inhibitors reduce infarct size by a platelet-dependent, aspirin-sensitive mechanism. Circ Res 62:668–678
Otani H, Otani H, Das DK (1988) Positive inotropic effect and phosphoinositide breakdown mediated by arachidonic acid and prostaglandin F2α. J Pharm Exp Ther 244:844–851
Ragazzi E, Salvador S, Froldi G (1990) Interaction of FCE 22176, a stable prostacyclin analogue, with different prostaglandins in guinea-pig trachea and atria. Pharmacol Res 22:263–269
Robleto DO, Reitmeyer ST, Herman CA (1988) Cardiac inotropic effects of leukotriene C4 and prostaglandin I2 in the unanesthetized American bullfrog, Rana catesbeiana. Can J Physiol Pharmacol 66:233–238
Roth DM, Reibel DK, Lefer AM (1984) Altered coronary vascular responsiveness to leukotrienes in alloxan-diabetic rats. Circ Res 54:388–395
Sakuma I, Gross SS, Levi R (1989) Positive inotropic effect of the thromboxane analogue U-46619 on guinea pig left atrium: mediation by specific receptors and association with increased phosphoinositide turnover. Can J Physiol Pharmacol 67:943–949
Schrör K (1978) Prostaglandin D2—a potent coronary vasoconstrictor agent in the guinea pig isolated heart. Naunyn-Schmiedeberg's Arch Pharmacol 302:61–62
Schrör K (1987) Actions of prostaglandins on the heart. In: Gryglewski RJ, Stock G (eds) Prostacyclin and its stable analog iloprost; Springer, Berlin Heidelberg, pp 159–178
Schrör K (1988) Cardiac muscle and coronary vessels. In: Curtis-Prior P (ed) Prostaglandins; Churchill-Livingstone, London, pp 238–268
Schrör K, Hohlfeld Th (1990) Eicosanoids and the ischemic myocardium. In: Piper HM (ed) Pathophysiology of severe myocardial injury; Kluwer, Dordrecht, Netherlands, pp 195–220
Schrör K, Link H-B, Rösen R, Klaus W, Rösen P (1980) Prostacyclin-induced coronary vasodilation. Interactions with adenosine, cyclic AMP and energy charge in the rat heart in vitro. Eur J Pharmacol 64:341–348
Schrör K, Moncada S (1979) Effect of prostacyclin on coronary circulation, heart rate and myocardial contractile force in isolated hearts of guinea pig and rabbit — comparison with prostaglandin E2. Prostaglandins 17:367–373
Shaffer JE, Malik KU (1984) Mechanism of action of arachidonic acid in the isolated perfused rat heart. Can J Physiol Pharmacol 62:551–558
Sterin-Borda L, Canga L, Borda ES, Gimeno MF, Gimeno AL (1980) Inotropic effect of prostacyclin (PGI2) on isolated rat atria at different contraction frequencies. Naunyn-Schmiedeberg's Arch Pharmacol 313:95–100
Sterin-Borda L, Canga L, Pissani A, Gimeno AL (1980) Inotropic effect of PGE1 and PGE2 on isolated rat atria. Influence of adrenergic mechanisms. Prostaglandins 20:825–836
Terashita ZI, Fukui H, Nishikawa K, Hirata M, Kikuchi S (1978) Coronary vasospastic action of thromboxane A2 in isolated, working guinea pig hearts. Eur J Pharmacol 53:49–56
Uemura S, Nakanishi T, Matsuoka S (1984) Inotropic effects of prostaglandin D2 and E1 on the newborn rabbit heart. Pediatr Res 18:1277–1281
Wennmalm M, FitzGerald GA, Wennmalm A (1987) Prostacyclin as neuromodulator in the sympathetically stimulated rabbit heart. Prostaglandins 33:675–691
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schrör, K., Hohlfeld, T. Inotropic actions of eicosanoids. Basic Res Cardiol 87, 2–11 (1992). https://doi.org/10.1007/BF00795384
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00795384